Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment

Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment

Abstract Biliary tract cancer (BTC) has greatly influenced patient survival for years. Nowadays, immunotherapy represents a promising breakthrough and proteomics is one of powerful technologies in biomarker research. We collected plasma and tissue samples from 37 patients with advanced BTC and 92 pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Shiyun Cui, Hejian Zheng, Yiyang Xu, Qiuyu Wu, Weici Liu, Yucheng Cai, Lei Fan, Yitong Tian, Hao Qian, Yuting Ding, Xinyi Zhang, Jiaguang Zhang, Xiaofeng Wu, Rong Wang, Xiangcheng Li, Xiaofeng Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00879-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41698-025-00879-9

Similar Items